论文部分内容阅读
据美国FDA官员指出,美国市场对中国产的草药保健产品看好。近年中草药已占美国100亿美元的医药保健市场3％的份额,估计2000年可达10％。
According to U.S. FDA officials, the U.S. market is bullish on herbal health products made in China. In recent years, Chinese herbal medicines have accounted for 3% of the U.S. $ 10 billion medical and healthcare market, with an estimated 10% in 2000.